10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CRMD (Cormedix) Stock Analysis
Buy, Hold or Sell?

Let's analyze Cormedix together

I guess you are interested in CorMedix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Cormedix’s Financial Insights
  • 📈 Technical Analysis (TA) – Cormedix’s Price Targets

I'm going to help you getting a better view of CorMedix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about CorMedix Inc

I send you an email if I find something interesting about CorMedix Inc.

1. Quick Overview

1.1. Quick analysis of Cormedix (30 sec.)










1.2. What can you expect buying and holding a share of Cormedix? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.67
Expected worth in 1 year
$2.48
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$0.81
Return On Investment
7.2%

For what price can you sell your share?

Current Price per Share
$11.28
Expected price per share
$8.72 - $17.43
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cormedix (5 min.)




Live pricePrice per Share (EOD)
$11.28
Intrinsic Value Per Share
$1.23 - $18.59
Total Value Per Share
$2.90 - $20.25

2.2. Growth of Cormedix (5 min.)




Is Cormedix growing?

Current yearPrevious yearGrowGrow %
How rich?$114.8m$65.1m$11m14.5%

How much money is Cormedix making?

Current yearPrevious yearGrowGrow %
Making money$4.2m-$12.5m$16.8m392.4%
Net Profit Margin-420.9%-1,212.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Cormedix (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#325 / 874

Most Revenue
#221 / 874

Most Profit
#106 / 874

Most Efficient
#643 / 874
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cormedix?

Welcome investor! Cormedix's management wants to use your money to grow the business. In return you get a share of Cormedix.

First you should know what it really means to hold a share of Cormedix. And how you can make/lose money.

Speculation

The Price per Share of Cormedix is $11.28. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cormedix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cormedix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.67. Based on the TTM, the Book Value Change Per Share is $0.20 per quarter. Based on the YOY, the Book Value Change Per Share is $0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cormedix.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.302.7%0.060.6%-0.19-1.6%-0.08-0.7%-0.09-0.8%-0.10-0.9%
Usd Book Value Change Per Share0.423.7%0.201.8%0.020.1%0.070.6%0.070.6%0.040.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.423.7%0.201.8%0.020.1%0.070.6%0.070.6%0.040.3%
Usd Price Per Share6.16-6.67-3.92-4.80-5.44-4.17-
Price to Earnings Ratio5.15--9.80--5.42--7.68--11.88--14.54-
Price-to-Total Gains Ratio14.76-13.71--22.76--33.53--39.82--264.25-
Price to Book Ratio3.70-6.47-4.27-5.10-6.88-8.56-
Price-to-Total Gains Ratio14.76-13.71--22.76--33.53--39.82--264.25-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.28
Number of shares88
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.200.07
Usd Total Gains Per Share0.200.07
Gains per Quarter (88 shares)17.835.93
Gains per Year (88 shares)71.3123.71
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10716102414
2014313204738
3021420307162
4028527409586
503573450119110
604284160142134
704994870166158
805705580190182
906426290213206
1007137000237230

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%2.018.00.010.0%3.037.00.07.5%5.060.01.07.6%
Book Value Change Per Share3.01.00.075.0%5.07.00.041.7%8.012.00.040.0%13.027.00.032.5%20.043.03.030.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%4.00.062.06.1%
Total Gains per Share3.01.00.075.0%5.07.00.041.7%8.012.00.040.0%13.027.00.032.5%20.043.03.030.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of CorMedix Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4170.203+106%0.015+2673%0.065+540%0.067+520%0.039+975%
Book Value Per Share--1.6661.115+49%0.960+74%0.971+72%0.911+83%0.584+185%
Current Ratio--4.2124.086+3%8.156-48%7.895-47%10.637-60%8.424-50%
Debt To Asset Ratio--0.2320.241-4%0.131+78%0.156+49%0.135+72%0.301-23%
Debt To Equity Ratio--0.3020.319-5%0.110+174%0.160+89%0.133+127%0.406-26%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--467696746.880484374933.480-3%324562261.540+44%373481259.827+25%419188261.054+12%315774168.245+48%
Eps--0.2990.062+382%-0.185+162%-0.082+127%-0.087+129%-0.098+133%
Ev To Ebitda Ratio--5.617-11.014+296%-6.561+217%-8.981+260%-12.358+320%-10.916+294%
Ev To Sales Ratio--2.99230.432-90%262.415-99%2014.933-100%3954.018-100%2438.838-100%
Free Cash Flow Per Share--0.286-0.051+118%-0.168+159%-0.108+138%-0.097+134%-0.088+131%
Free Cash Flow To Equity Per Share--0.3740.068+451%0.011+3378%0.019+1901%0.060+521%0.035+956%
Gross Profit Margin--0.7831.530-49%1.072-27%1.201-35%1.121-30%1.061-26%
Intrinsic Value_10Y_max--18.587----------
Intrinsic Value_10Y_min--1.232----------
Intrinsic Value_1Y_max---0.032----------
Intrinsic Value_1Y_min---0.340----------
Intrinsic Value_3Y_max--1.347----------
Intrinsic Value_3Y_min---0.626----------
Intrinsic Value_5Y_max--4.467----------
Intrinsic Value_5Y_min---0.476----------
Market Cap765062661.120+44%424888574.880453993313.480-6%265618497.040+60%325838415.827+30%369439502.904+15%283095754.245+50%
Net Profit Margin--0.528-4.209+897%-12.129+2396%-140.250+26651%-201.259+38201%-186.657+35437%
Operating Margin----4.3390%-12.1290%-144.2720%-227.2240%-202.9250%
Operating Ratio--0.4855.585-91%12.881-96%147.358-100%229.131-100%202.590-100%
Pb Ratio6.772+45%3.6986.470-43%4.273-13%5.100-27%6.885-46%8.561-57%
Pe Ratio9.422+45%5.145-9.795+290%-5.423+205%-7.683+249%-11.876+331%-14.543+383%
Price Per Share11.280+45%6.1606.668-8%3.916+57%4.795+28%5.442+13%4.171+48%
Price To Free Cash Flow Ratio9.860+45%5.385-8.570+259%-6.239+216%-8.144+251%-18.725+448%10.007-46%
Price To Total Gains Ratio27.020+45%14.75613.711+8%-22.758+254%-33.527+327%-39.816+370%-264.247+1891%
Quick Ratio--4.1684.316-3%11.322-63%10.235-59%12.563-67%10.624-61%
Return On Assets--0.138-0.007+105%-0.174+226%0.516-73%0.264-48%-0.065+147%
Return On Equity--0.180-0.004+102%-0.144+180%-0.070+139%-0.081+145%-0.449+350%
Total Gains Per Share--0.4170.203+106%0.015+2673%0.065+540%0.067+520%0.039+975%
Usd Book Value--114888048.00076110299.250+51%65102020.000+76%65990632.750+74%61914866.650+86%39644438.575+190%
Usd Book Value Change Per Share--0.4170.203+106%0.015+2673%0.065+540%0.067+520%0.039+975%
Usd Book Value Per Share--1.6661.115+49%0.960+74%0.971+72%0.911+83%0.584+185%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--467696746.880484374933.480-3%324562261.540+44%373481259.827+25%419188261.054+12%315774168.245+48%
Usd Eps--0.2990.062+382%-0.185+162%-0.082+127%-0.087+129%-0.098+133%
Usd Free Cash Flow--19726326.000-3408114.250+117%-11424932.000+158%-7297355.250+137%-6550045.650+133%-5976504.975+130%
Usd Free Cash Flow Per Share--0.286-0.051+118%-0.168+159%-0.108+138%-0.097+134%-0.088+131%
Usd Free Cash Flow To Equity Per Share--0.3740.068+451%0.011+3378%0.019+1901%0.060+521%0.035+956%
Usd Market Cap765062661.120+44%424888574.880453993313.480-6%265618497.040+60%325838415.827+30%369439502.904+15%283095754.245+50%
Usd Price Per Share11.280+45%6.1606.668-8%3.916+57%4.795+28%5.442+13%4.171+48%
Usd Profit--20643898.0004295000.250+381%-12559531.250+161%31264385.750-34%16172812.950+28%5107295.625+304%
Usd Revenue--39081657.00020638456.750+89%76027.500+51305%6909642.417+466%4163972.900+839%2119971.875+1743%
Usd Total Gains Per Share--0.4170.203+106%0.015+2673%0.065+540%0.067+520%0.039+975%
 EOD+4 -4MRQTTM+27 -10YOY+28 -93Y+26 -115Y+27 -1010Y+31 -6

3.3 Fundamental Score

Let's check the fundamental score of CorMedix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.422
Price to Book Ratio (EOD)Between0-16.772
Net Profit Margin (MRQ)Greater than00.528
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.168
Current Ratio (MRQ)Greater than14.212
Debt to Asset Ratio (MRQ)Less than10.232
Debt to Equity Ratio (MRQ)Less than10.302
Return on Equity (MRQ)Greater than0.150.180
Return on Assets (MRQ)Greater than0.050.138
Total8/10 (80.0%)

3.4 Technical Score

Let's check the technical score of CorMedix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.639
Ma 20Greater thanMa 5013.673
Ma 50Greater thanMa 10012.405
Ma 100Greater thanMa 20010.688
OpenGreater thanClose11.480
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Fundamental data was last updated by Penke on 2025-06-19 03:13:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cormedix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • A Net Profit Margin of 52.8% means that $0.53 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CorMedix Inc:

  • The MRQ is 52.8%. The company is making a huge profit. +2
  • The TTM is -420.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ52.8%TTM-420.9%+473.8%
TTM-420.9%YOY-1,212.9%+791.9%
TTM-420.9%5Y-20,125.9%+19,705.0%
5Y-20,125.9%10Y-18,665.7%-1,460.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ52.8%-92.7%+145.5%
TTM-420.9%-140.3%-280.6%
YOY-1,212.9%-196.4%-1,016.5%
3Y-14,025.0%-248.5%-13,776.5%
5Y-20,125.9%-343.4%-19,782.5%
10Y-18,665.7%-496.2%-18,169.5%
4.3.1.2. Return on Assets

Shows how efficient Cormedix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • 13.8% Return on Assets means that Cormedix generated $0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CorMedix Inc:

  • The MRQ is 13.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is -0.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ13.8%TTM-0.7%+14.5%
TTM-0.7%YOY-17.4%+16.7%
TTM-0.7%5Y26.4%-27.1%
5Y26.4%10Y-6.5%+32.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.8%-11.6%+25.4%
TTM-0.7%-11.6%+10.9%
YOY-17.4%-11.4%-6.0%
3Y51.6%-11.8%+63.4%
5Y26.4%-12.0%+38.4%
10Y-6.5%-13.7%+7.2%
4.3.1.3. Return on Equity

Shows how efficient Cormedix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • 18.0% Return on Equity means Cormedix generated $0.18 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CorMedix Inc:

  • The MRQ is 18.0%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is -0.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ18.0%TTM-0.4%+18.3%
TTM-0.4%YOY-14.4%+14.0%
TTM-0.4%5Y-8.1%+7.7%
5Y-8.1%10Y-44.9%+36.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.0%-13.6%+31.6%
TTM-0.4%-15.0%+14.6%
YOY-14.4%-14.5%+0.1%
3Y-7.0%-16.9%+9.9%
5Y-8.1%-17.5%+9.4%
10Y-44.9%-19.9%-25.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of CorMedix Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cormedix is operating .

  • Measures how much profit Cormedix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CorMedix Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-433.9%+433.9%
TTM-433.9%YOY-1,212.9%+779.0%
TTM-433.9%5Y-22,722.4%+22,288.5%
5Y-22,722.4%10Y-20,292.5%-2,430.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM-433.9%-249.0%-184.9%
YOY-1,212.9%-208.5%-1,004.4%
3Y-14,427.2%-223.8%-14,203.4%
5Y-22,722.4%-346.1%-22,376.3%
10Y-20,292.5%-475.5%-19,817.0%
4.3.2.2. Operating Ratio

Measures how efficient Cormedix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.49 means that the operating costs are $0.49 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CorMedix Inc:

  • The MRQ is 0.485. The company is very efficient in keeping operating costs low. +2
  • The TTM is 5.585. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.485TTM5.585-5.100
TTM5.585YOY12.881-7.296
TTM5.5855Y229.131-223.546
5Y229.13110Y202.590+26.541
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4852.110-1.625
TTM5.5852.684+2.901
YOY12.8813.096+9.785
3Y147.3583.652+143.706
5Y229.1314.745+224.386
10Y202.5906.614+195.976
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of CorMedix Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cormedix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.21 means the company has $4.21 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CorMedix Inc:

  • The MRQ is 4.212. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.086. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.212TTM4.086+0.126
TTM4.086YOY8.156-4.070
TTM4.0865Y10.637-6.551
5Y10.63710Y8.424+2.212
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2123.661+0.551
TTM4.0863.846+0.240
YOY8.1564.140+4.016
3Y7.8954.688+3.207
5Y10.6375.746+4.891
10Y8.4246.147+2.277
4.4.3.2. Quick Ratio

Measures if Cormedix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • A Quick Ratio of 4.17 means the company can pay off $4.17 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CorMedix Inc:

  • The MRQ is 4.168. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.316. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.168TTM4.316-0.149
TTM4.316YOY11.322-7.006
TTM4.3165Y12.563-8.247
5Y12.56310Y10.624+1.939
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1682.826+1.342
TTM4.3163.182+1.134
YOY11.3223.786+7.536
3Y10.2354.311+5.924
5Y12.5635.703+6.860
10Y10.6246.454+4.170
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of CorMedix Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cormedix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cormedix to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.23 means that Cormedix assets are financed with 23.2% credit (debt) and the remaining percentage (100% - 23.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CorMedix Inc:

  • The MRQ is 0.232. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.241. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.232TTM0.241-0.009
TTM0.241YOY0.131+0.110
TTM0.2415Y0.135+0.106
5Y0.13510Y0.301-0.166
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2320.329-0.097
TTM0.2410.349-0.108
YOY0.1310.331-0.200
3Y0.1560.340-0.184
5Y0.1350.349-0.214
10Y0.3010.379-0.078
4.5.4.2. Debt to Equity Ratio

Measures if Cormedix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • A Debt to Equity ratio of 30.2% means that company has $0.30 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CorMedix Inc:

  • The MRQ is 0.302. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.319. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.302TTM0.319-0.017
TTM0.319YOY0.110+0.209
TTM0.3195Y0.133+0.186
5Y0.13310Y0.406-0.273
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3020.379-0.077
TTM0.3190.437-0.118
YOY0.1100.414-0.304
3Y0.1600.450-0.290
5Y0.1330.464-0.331
10Y0.4060.515-0.109
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cormedix generates.

  • Above 15 is considered overpriced but always compare Cormedix to the Biotechnology industry mean.
  • A PE ratio of 5.15 means the investor is paying $5.15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CorMedix Inc:

  • The EOD is 9.422. Based on the earnings, the company is underpriced. +1
  • The MRQ is 5.145. Based on the earnings, the company is cheap. +2
  • The TTM is -9.795. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD9.422MRQ5.145+4.277
MRQ5.145TTM-9.795+14.941
TTM-9.795YOY-5.423-4.372
TTM-9.7955Y-11.876+2.081
5Y-11.87610Y-14.543+2.667
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.422-2.320+11.742
MRQ5.145-2.085+7.230
TTM-9.795-2.564-7.231
YOY-5.423-3.764-1.659
3Y-7.683-3.773-3.910
5Y-11.876-6.167-5.709
10Y-14.543-6.833-7.710
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CorMedix Inc:

  • The EOD is 9.860. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 5.385. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -8.570. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD9.860MRQ5.385+4.476
MRQ5.385TTM-8.570+13.955
TTM-8.570YOY-6.239-2.332
TTM-8.5705Y-18.725+10.155
5Y-18.72510Y10.007-28.732
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.860-3.219+13.079
MRQ5.385-2.705+8.090
TTM-8.570-3.666-4.904
YOY-6.239-4.403-1.836
3Y-8.144-5.059-3.085
5Y-18.725-8.477-10.248
10Y10.007-9.291+19.298
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cormedix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.70 means the investor is paying $3.70 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of CorMedix Inc:

  • The EOD is 6.772. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.698. Based on the equity, the company is fair priced.
  • The TTM is 6.470. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.772MRQ3.698+3.074
MRQ3.698TTM6.470-2.772
TTM6.470YOY4.273+2.197
TTM6.4705Y6.885-0.414
5Y6.88510Y8.561-1.676
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.7721.952+4.820
MRQ3.6981.842+1.856
TTM6.4702.112+4.358
YOY4.2732.439+1.834
3Y5.1002.494+2.606
5Y6.8853.655+3.230
10Y8.5614.311+4.250
4.6.2. Total Gains per Share

2.4. Latest News of CorMedix Inc

Does CorMedix Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from CorMedix Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-07-02
23:41
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on Your BehalfRead
2025-06-28
00:14
S&P 500 and Nasdaq Climb to Record Highs on China Trade OptimismRead
2025-06-27
22:40
S&P 500 and Nasdaq Climb to Record Highs on China Trade OptimismRead
2025-06-27
20:01
Palantir, Nike lead Friday's market cap stock moversRead
2025-06-27
19:04
Stocks Rally on Hopes of Trade DealsRead
2025-06-27
18:30
CorMedix Prices $85 Mln Public Offering Of Common StockRead
2025-06-26
22:55
Stocks making the biggest moves after hours: Nike, Core Scientific & moreRead
2025-06-26
22:10
CorMedix to launch $85M proposed public offeringRead
2025-06-26
22:09
CorMedix plans $85 million common stock offeringRead
2025-06-26
22:08
CorMedix stock falls after $85 million share offering announcementRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of CorMedix Inc.

4.8.1. Institutions holding CorMedix Inc

Institutions are holding 37.167% of the shares of CorMedix Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc6.96790.000647259751580783.4606
2025-03-31Vanguard Group Inc5.37640.000436465512683607.9439
2025-03-31Elliott Investment Management LP3.60420.09942444561-426071-14.8424
2025-03-31State Street Corp2.26930.00041539123859755.9165
2025-03-31Geode Capital Management, LLC2.11270.00071432919400992.879
2025-03-31Morgan Stanley - Brokerage Accounts1.03760.000370374030489176.4427
2025-03-31Northern Trust Corp0.76150.000551651749520.968
2025-03-31Oberweis Asset Management Inc0.71510.14894850004850000
2024-12-31D. E. Shaw & Co LP0.65820.002744641412542539.0745
2025-03-31Kennedy Capital Management Inc0.5960.0595404231259886.8707
2024-12-31UBS Group AG0.56010.0006379868340352861.3018
2025-03-31Millennium Management LLC0.54720.0012371126192992108.3409
2025-03-31Palisades Investment Partners, LLC0.52931.1096358970-5049-1.387
2025-03-31Susquehanna International Group, LLP0.47530.00033223502956231106.0837
2025-03-31Amvescap Plc.0.42630.00032891102644071070.3437
2025-03-31Nuveen, LLC0.4050.00052746812746810
2025-03-31ExodusPoint Capital Management, LP0.34130.0141231467152178191.9283
2025-03-31Marshall Wace Asset Management Ltd0.33990.00182305252305250
2025-03-31Goldman Sachs Group Inc0.26510.0002179798-19122-9.6129
2025-03-31Charles Schwab Investment Management Inc0.26120.000217718827701.5881
Total 28.24961.442219160114+2802054+14.6%

4.9.2. Funds holding CorMedix Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv2.91760.0011197887100
2025-05-31iShares Russell 2000 ETF2.23580.0299151642600
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.41790.008796166114460.1506
2025-03-31Fidelity Small Cap Index0.89490.015560699045380.7533
2025-03-31Oberweis Micro-Cap Growth0.71510.50264850004850000
2025-03-31Oberweis Micro-Cap0.71510.5034850004850000
2025-05-31iShares Russell 2000 Growth ETF0.69790.05247335500
2025-05-31State St Russell Sm/Mid Cp® Indx SL Cl I0.53140.010636040900
2025-05-31iShares Biotechnology ETF0.52180.086135393900
2025-04-30Fidelity Extended Market Index0.49130.0085333191-3185-0.9469
2025-03-31Kennedy Micro Cap0.47120.4149319597-1688-0.5254
2025-04-30Vanguard Russell 2000 ETF0.44630.0235302691204647.2509
2025-05-31Swedbank Robur Healthcare A0.36860.196425000000
2025-05-30Invesco Dorsey Wright SmallCap Momt ETF0.36790.4724951200
2025-05-31State St Russell Sm Cap® Indx SL Cl I0.31960.030421680000
2025-05-31SPDR® S&P Pharmaceuticals ETF0.24691.45316745000
2025-03-31Vanguard US Momentum Factor ETF0.23480.10261592623537028.5491
2025-04-30Schwab Small Cap Index0.2240.023915191633362.2453
2025-03-31NT R2000 Index Fund - NL0.21320.0153144575-1457-0.9977
2025-03-31Palisades Small Cap Core0.21021.085714260000
Total 14.24155.03379659245+1028824+10.7%

5.3. Insider Transactions

Insiders are holding 1.188% of the shares of CorMedix Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-11-14Elizabeth HurlburtSELL14002711.18
2024-10-31Erin MistryBUY15009.99
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets149,583
Total Liabilities34,695
Total Stockholder Equity114,888
 As reported
Total Liabilities 34,695
Total Stockholder Equity+ 114,888
Total Assets = 149,583

Assets

Total Assets149,583
Total Current Assets144,862
Long-term Assets4,721
Total Current Assets
Cash And Cash Equivalents 66,286
Short-term Investments 11,217
Net Receivables 54,611
Inventory 7,488
Other Current Assets 2,491
Total Current Assets  (as reported)144,862
Total Current Assets  (calculated)142,093
+/- 2,768
Long-term Assets
Property Plant Equipment 2,182
Intangible Assets 1,792
Long-term Assets Other 747
Long-term Assets  (as reported)4,721
Long-term Assets  (calculated)4,721
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities34,391
Long-term Liabilities304
Total Stockholder Equity114,888
Total Current Liabilities
Short-term Debt 172
Accounts payable 1,933
Other Current Liabilities 2,000
Total Current Liabilities  (as reported)34,391
Total Current Liabilities  (calculated)4,106
+/- 30,285
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt304
Long-term Liabilities  (as reported)304
Long-term Liabilities  (calculated)304
+/-0
Total Stockholder Equity
Common Stock68
Total Stockholder Equity (as reported)114,888
Total Stockholder Equity (calculated)68
+/- 114,820
Other
Capital Stock68
Cash and Short Term Investments 77,503
Common Stock Shares Outstanding 68,975
Liabilities and Stockholders Equity 149,583
Net Debt -65,809
Net Invested Capital 114,888
Net Working Capital 110,471
Property Plant and Equipment Gross 2,182
Short Long Term Debt Total 477



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312007-12-31
> Total Assets 
4,113
1,620
0
0
0
2,226
12,070
10,991
9,733
8,848
6,819
4,949
3,031
2,556
2,035
1,036
1,257
1,153
968
395
1,037
2,968
9,761
8,256
6,845
5,098
9,752
38,796
39,307
37,102
33,610
31,213
28,840
21,906
14,933
21,156
13,929
13,454
9,609
5,927
8,049
18,826
27,308
27,559
33,717
29,476
27,400
24,237
40,023
49,308
84,259
80,857
75,389
68,946
64,934
67,748
62,077
62,038
59,234
57,033
91,429
82,060
68,024
57,731
77,586
118,846
149,583
149,583118,84677,58657,73168,02482,06091,42957,03359,23462,03862,07767,74864,93468,94675,38980,85784,25949,30840,02324,23727,40029,47633,71727,55927,30818,8268,0495,9279,60913,45413,92921,15614,93321,90628,84031,21333,61037,10239,30738,7969,7525,0986,8458,2569,7612,9681,0373959681,1531,2571,0362,0352,5563,0314,9496,8198,8489,73310,99112,0702,2260001,6204,113
   > Total Current Assets 
0
0
0
0
0
1,683
12,016
10,952
9,694
8,812
6,786
4,918
3,003
2,531
2,012
1,000
1,238
1,135
950
378
1,020
2,916
9,714
8,188
6,785
5,038
9,686
38,746
39,261
37,059
33,570
31,176
28,760
21,832
14,865
21,094
13,853
13,268
9,404
5,741
7,870
18,665
27,142
27,413
33,583
29,349
27,281
24,134
38,865
48,182
83,057
79,691
72,991
66,469
62,503
65,359
59,664
59,551
56,781
54,625
89,062
79,450
63,410
53,194
73,154
114,575
144,862
144,862114,57573,15453,19463,41079,45089,06254,62556,78159,55159,66465,35962,50366,46972,99179,69183,05748,18238,86524,13427,28129,34933,58327,41327,14218,6657,8705,7419,40413,26813,85321,09414,86521,83228,76031,17633,57037,05939,26138,7469,6865,0386,7858,1889,7142,9161,0203789501,1351,2381,0002,0122,5313,0034,9186,7868,8129,69410,95212,0161,68300000
       Cash And Cash Equivalents 
0
1,380
0
0
0
1,505
11,725
10,586
9,522
8,284
6,564
4,738
2,890
1,985
1,855
894
992
835
693
158
483
2,374
9,189
7,652
5,920
4,340
8,799
24,111
14,247
11,817
13,185
12,021
9,827
8,064
6,819
7,937
5,213
10,380
8,162
4,702
6,444
17,624
18,257
14,733
20,145
16,525
12,205
16,494
34,365
42,097
76,215
73,093
66,316
53,551
45,389
48,930
43,254
43,375
25,497
19,889
53,314
43,720
35,256
28,541
35,286
40,651
66,286
66,28640,65135,28628,54135,25643,72053,31419,88925,49743,37543,25448,93045,38953,55166,31673,09376,21542,09734,36516,49412,20516,52520,14514,73318,25717,6246,4444,7028,16210,3805,2137,9376,8198,0649,82712,02113,18511,81714,24724,1118,7994,3405,9207,6529,1892,3744831586938359928941,8551,9852,8904,7386,5648,2849,52210,58611,7251,5050001,3800
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
220
221
221
0
0
0
132
13,377
23,605
23,568
17,044
16,591
16,827
12,101
6,951
10,884
6,796
1,604
1,604
172
172
0
7,945
11,825
12,294
11,984
10,983
5,948
2,675
4,444
4,957
5,159
5,653
12,149
16,298
15,693
15,746
15,644
30,332
32,701
33,273
32,388
23,371
17,070
10,744
11,037
11,217
11,21711,03710,74417,07023,37132,38833,27332,70130,33215,64415,74615,69316,29812,1495,6535,1594,9574,4442,6755,94810,98311,98412,29411,8257,94501721721,6041,6046,79610,8846,95112,10116,82716,59117,04423,56823,60513,37713200022122122000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
494
494
0
0
0
0
0
0
2
14
55
46
80
69
113
125
316
345
6
22
12
76
154
89
64
9
3
302
11
34
-172
4
0
7
11
6
3
44
3
0
45
3
0
0
0
0
0
0
0
0
706
17,387
51,654
54,611
54,61151,65417,3877060000000034503443611704-17234113023964891547612226345316125113698046551420000004944940000000000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
271
80
64
278
677
463
461
715
699
377
334
158
118
167
95
313
299
594
579
673
341
429
420
403
381
338
295
278
201
144
85
73
49
3
3
2
0
0
0
0
0
2,106
2,320
4,012
6,649
7,600
7,488
7,4887,6006,6494,0122,3202,1060000023349738514420127829533838140342042934167357959429931395167118158334377699715461463677278648027100000000000000000000
   > Long-term Assets 
0
0
0
0
0
542
53
39
39
36
33
31
28
25
23
37
20
18
17
17
16
52
47
68
60
60
65
50
46
43
40
37
81
75
68
62
76
186
205
186
178
161
166
147
135
127
119
103
1,157
1,126
1,202
1,167
2,399
2,477
2,430
2,389
2,413
2,487
2,452
2,408
2,367
2,610
4,614
4,536
4,432
4,270
4,721
4,7214,2704,4324,5364,6142,6102,3672,4082,4522,4872,4132,3892,4302,4772,3991,1671,2021,1261,1571031191271351471661611781862051867662687581374043465065606068475216171718203723252831333639395354200000
       Property Plant Equipment 
44
34
0
0
0
24
28
25
26
22
19
18
15
12
10
8
6
5
4
4
3
36
34
54
47
41
47
45
41
38
35
32
76
70
63
57
71
186
205
186
178
161
166
147
135
127
119
103
1,157
1,126
1,099
1,064
2,296
2,374
2,328
2,286
2,310
2,385
2,350
2,306
2,264
2,507
2,510
2,484
2,431
2,321
2,182
2,1822,3212,4312,4842,5102,5072,2642,3062,3502,3852,3102,2862,3282,3742,2961,0641,0991,1261,15710311912713514716616117818620518671576370763235384145474147543436344568101215181922262528240003444
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
1,948
1,896
1,844
1,792
1,7921,8441,8961,9482,00000000000000000000000000000000000000000000000000000000000000000
       Long-term Assets Other 
0
0
0
0
0
507
0
0
0
0
0
13
13
13
13
15
13
13
13
13
13
16
13
13
13
18
18
5
5
5
5
5
5
5
5
5
5
0
0
0
0
0
166
147
135
127
119
0
1,042
1,015
102
102
102
102
102
102
102
102
-30,302,058
102
103
0
2,101,838
2,050,530
105
105
747
7471051052,050,5302,101,8380103102-30,302,0581021021021021021021021021,0151,0420119127135147166000005555555555181813131316131313131315131313130000050700000
> Total Liabilities 
0
13,647
0
0
0
16,935
1,421
1,171
956
1,592
1,459
1,715
2,293
1,319
1,612
1,180
1,374
1,629
2,244
2,589
3,945
6,990
13,490
9,856
1,267
1,463
2,156
1,945
2,915
3,090
3,090
3,142
5,061
4,092
3,890
5,790
4,252
6,261
8,768
12,405
17,546
13,892
10,766
11,084
5,010
5,830
5,806
5,716
5,553
5,085
3,944
3,988
6,045
6,148
5,064
6,009
5,765
6,979
5,306
7,982
8,227
11,918
10,011
11,547
18,874
34,189
34,695
34,69534,18918,87411,54710,01111,9188,2277,9825,3066,9795,7656,0095,0646,1486,0453,9883,9445,0855,5535,7165,8065,8305,01011,08410,76613,89217,54612,4058,7686,2614,2525,7903,8904,0925,0613,1423,0903,0902,9151,9452,1561,4631,2679,85613,4906,9903,9452,5892,2441,6291,3741,1801,6121,3192,2931,7151,4591,5929561,1711,42116,93500013,6470
   > Total Current Liabilities 
1,212
13,647
0
0
0
16,935
1,421
1,152
938
1,576
1,443
1,700
2,278
1,305
1,598
1,166
1,362
1,616
2,233
2,579
3,937
1,674
1,122
1,181
1,227
1,425
2,120
1,912
2,882
3,061
3,064
3,118
5,039
4,092
3,890
5,790
4,252
6,261
8,768
12,405
17,546
7,766
4,335
4,346
5,007
5,827
5,804
5,714
4,601
4,162
3,049
3,123
5,211
5,345
4,294
5,272
5,062
6,311
4,675
7,387
7,671
11,401
9,534
11,111
18,481
33,840
34,391
34,39133,84018,48111,1119,53411,4017,6717,3874,6756,3115,0625,2724,2945,3455,2113,1233,0494,1624,6015,7145,8045,8275,0074,3464,3357,76617,54612,4058,7686,2614,2525,7903,8904,0925,0393,1183,0643,0612,8821,9122,1201,4251,2271,1811,1221,6743,9372,5792,2331,6161,3621,1661,5981,3052,2781,7001,4431,5769381,1521,42116,93500013,6471,212
       Short-term Debt 
0
0
0
0
0
13,765
0
0
0
0
0
0
0
0
0
0
126
254
599
696
1,535
0
0
0
0
0
0
66
70
67
71
1
3
2
13
2,042
0
0
0
0
0
0
2
0
0
2
0
0
196
109
112
116
118
121
124
127
262
135
139
285
147
151
155
159
163
168
172
1721681631591551511472851391352621271241211181161121091960020020000002,04213231716770660000001,535696599254126000000000013,76500000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,880
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000020000001,88000000000000000000000000000000000000
       Accounts payable 
1,212
822
0
0
0
550
1,046
804
517
1,139
1,294
1,437
990
913
1,425
994
918
929
1,312
1,489
970
940
1,027
849
740
893
1,429
1,142
1,425
1,709
1,581
1,109
1,758
1,645
1,726
1,766
1,408
1,808
3,660
7,309
7,882
2,589
1,462
906
1,055
1,024
1,333
1,386
1,986
1,128
1,500
943
1,107
2,210
1,740
2,496
1,767
2,202
1,447
2,901
2,386
4,280
2,826
3,345
1,344
1,720
1,933
1,9331,7201,3443,3452,8264,2802,3862,9011,4472,2021,7672,4961,7402,2101,1079431,5001,1281,9861,3861,3331,0241,0559061,4622,5897,8827,3093,6601,8081,4081,7661,7261,6451,7581,1091,5811,7091,4251,1421,4298937408491,0279409701,4891,3129299189941,4259139901,4371,2941,1395178041,0465500008221,212
       Other Current Liabilities 
0
1,172
0
0
0
2,620
375
348
421
436
149
263
1,288
392
174
173
318
434
322
394
1,432
734
95
332
478
522
682
695
1,380
1,154
1,276
1,876
3,146
2,341
2,050
3,922
2,758
4,364
5,091
5,080
9,651
5,166
2,864
3,434
3,947
4,798
4,471
4,328
2,419
2,924
1,437
2,064
3,986
3,014
2,430
2,649
3,032
3,974
3,089
4,202
5,138
6,970
6,553
7,608
16,974
8,530
2,000
2,0008,53016,9747,6086,5536,9705,1384,2023,0893,9743,0322,6492,4303,0143,9862,0641,4372,9242,4194,3284,4714,7983,9473,4342,8645,1669,6515,0805,0914,3642,7583,9222,0502,3413,1461,8761,2761,1541,380695682522478332957341,4323943224343181731743921,2882631494364213483752,6200001,1720
   > Long-term Liabilities 
0
0
0
0
0
0
0
19
18
17
16
16
15
14
14
13
13
12
11
10
8
5,316
12,368
8,676
40
38
36
33
33
29
27
24
22
0
0
0
0
0
0
0
0
6,125
6,431
6,738
3
3
2
2
952
924
894
864
834
802
770
737
703
668
631
594
556
517
477
435
393
349
304
30434939343547751755659463166870373777080283486489492495222336,7386,4316,125000000002224272933333638408,67612,3685,3168101112131314141516161718190000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,125
6,427
6,734
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000006,7346,4276,12500000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-13,765
0
0
0
0
0
0
0
0
0
0
-126
-254
-599
-696
-1,535
0
0
0
0
0
0
-66
-70
-67
-71
-1
-3
-2
-13
-2,042
0
0
0
0
0
0
2
3
3
1
2
2
854
924
894
864
834
802
770
737
572
668
631
452
556
517
477
435
393
349
304
304349393435477517556452631668572737770802834864894924854221332000000-2,042-13-2-3-1-71-67-70-66000000-1,535-696-599-254-1260000000000-13,76500000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
3
3
3
2
2
952
924
894
864
834
802
770
737
703
0
631
594
0
0
0
0
0
0
0
00000005946310703737770802834864894924952223334000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
16
15
14
14
13
13
12
11
10
8
5,316
12,368
8,676
40
38
36
33
33
29
27
24
22
29
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000292224272933333638408,67612,3685,316810111213131414151600000000000
> Total Stockholder Equity
0
0
0
0
0
-14,709
10,649
9,820
8,777
7,255
5,360
3,234
738
1,237
423
-143
-117
-475
-1,276
-2,194
-2,909
-4,022
-3,729
-1,601
5,578
3,634
7,596
36,851
36,392
34,011
30,519
28,071
23,779
17,815
11,043
15,366
9,676
-152,175
841
-6,478
-9,498
-178,988
16,542
-184,852
28,708
-195,421
21,593
18,521
34,469
-217,449
80,315
76,870
69,344
-245,659
59,869
61,739
56,312
-275,361
-285,928
-297,202
83,202
70,142
58,013
46,184
58,712
84,657
114,888
114,88884,65758,71246,18458,01370,14283,202-297,202-285,928-275,36156,31261,73959,869-245,65969,34476,87080,315-217,44934,46918,52121,593-195,42128,708-184,85216,542-178,988-9,498-6,478841-152,1759,67615,36611,04317,81523,77928,07130,51934,01136,39236,8517,5963,6345,578-1,601-3,729-4,022-2,909-2,194-1,276-475-117-1434231,2377383,2345,3607,2558,7779,82010,649-14,70900000
   Retained Earnings -318,986-339,630-353,094-350,318-336,166-321,700-306,946-297,202-285,928-275,361-267,152-260,298-252,693-245,659-237,868-229,299-224,666-217,449-211,362-204,761-200,979-195,421-190,117-184,852-184,156-178,988-181,136-170,900-162,342-152,175-141,864-131,908-126,762-119,165-112,636-103,510-98,623-94,392-90,525-85,837-81,702-76,204-73,990-68,955-72,491-55,751-52,464-49,772-47,811-46,373-45,185-44,482-43,858-42,948-43,288-40,688-38,211-36,236-34,733-33,341-32,168-25,33100000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
-26
0
0
0
-38
-38
0
0
0
0
0
0
-57
0
0
0
-9
-11
-1
117
99
102
93
100
62
93
90
83
81
90
97
95
98
97
97
91
97
95
104
102
97
91
106
100
102
99
99
96
87
50
40
46
83
101
91
84
94
83
86
89
0
0
008986839484911018346405087969999102100106919710210495979197979895979081839093621009310299117-1-11-9000-57000000-38-38000-2600000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
43,912
44,015
44,173
44,269
44,327
45,057
45,887
46,652
47,694
49,539
51,720
68,750
67,332
79,427
79,716
89,168
122,560
126,781
128,305
129,012
131,452
136,291
136,857
137,674
147,117
151,384
159,198
163,004
164,239
171,449
183,717
200,579
201,199
218,697
218,944
222,455
223,151
245,700
261,536
304,844
306,031
307,079
308,332
312,474
321,956
323,377
0
339,710
346,116
0
0
0
0
0
0
0
0000000346,116339,7100323,377321,956312,474308,332307,079306,031304,844261,536245,700223,151222,455218,944218,697201,199200,579183,717171,449164,239163,004159,198151,384147,117137,674136,857136,291131,452129,012128,305126,781122,56089,16879,71679,42767,33268,75051,72049,53947,69446,65245,88745,05744,32744,26944,17344,01543,91200000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000-1-1



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue43,472
Cost of Revenue-3,191
Gross Profit40,28240,282
 
Operating Income (+$)
Gross Profit40,282
Operating Expense-62,638
Operating Income-22,356-22,356
 
Operating Expense (+$)
Research Development3,942
Selling General Administrative29,959
Selling And Marketing Expenses28,737
Operating Expense62,63862,638
 
Net Interest Income (+$)
Interest Income2,579
Interest Expense-36
Other Finance Cost-0
Net Interest Income2,542
 
Pretax Income (+$)
Operating Income-22,356
Net Interest Income2,542
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-19,325-25,388
EBIT - interestExpense = -19,325
-19,325
-17,894
Interest Expense36
Earnings Before Interest and Taxes (EBIT)-19,288-19,288
Earnings Before Interest and Taxes (EBITDA)-18,831
 
After tax Income (+$)
Income Before Tax-19,325
Tax Provision--1,395
Net Income From Continuing Ops-17,930-17,930
Net Income-17,930
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses65,829
Total Other Income/Expenses Net3,032-2,542
 

Technical Analysis of Cormedix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cormedix. The general trend of Cormedix is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cormedix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Cormedix Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CorMedix Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 11.88 < 17.43.

The bearish price targets are: 11.32 > 11.28 > 8.72.

Know someone who trades $CRMD? Share this with them.👇

CorMedix Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CorMedix Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CorMedix Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CorMedix Inc. The current macd is -0.29294787.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cormedix price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cormedix. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cormedix price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
CorMedix Inc Daily Moving Average Convergence/Divergence (MACD) ChartCorMedix Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CorMedix Inc. The current adx is 27.86.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cormedix shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
CorMedix Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CorMedix Inc. The current sar is 15.85.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
CorMedix Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CorMedix Inc. The current rsi is 37.64. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
CorMedix Inc Daily Relative Strength Index (RSI) ChartCorMedix Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CorMedix Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cormedix price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
CorMedix Inc Daily Stochastic Oscillator ChartCorMedix Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CorMedix Inc. The current cci is -119.52835765.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
CorMedix Inc Daily Commodity Channel Index (CCI) ChartCorMedix Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CorMedix Inc. The current cmo is -39.55737034.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
CorMedix Inc Daily Chande Momentum Oscillator (CMO) ChartCorMedix Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CorMedix Inc. The current willr is -98.87459807.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
CorMedix Inc Daily Williams %R ChartCorMedix Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CorMedix Inc.

CorMedix Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CorMedix Inc. The current atr is 0.79499873.

CorMedix Inc Daily Average True Range (ATR) ChartCorMedix Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CorMedix Inc. The current obv is 12,403,931.

CorMedix Inc Daily On-Balance Volume (OBV) ChartCorMedix Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CorMedix Inc. The current mfi is 22.68.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
CorMedix Inc Daily Money Flow Index (MFI) ChartCorMedix Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CorMedix Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

CorMedix Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CorMedix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.639
Ma 20Greater thanMa 5013.673
Ma 50Greater thanMa 10012.405
Ma 100Greater thanMa 20010.688
OpenGreater thanClose11.480
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cormedix with someone you think should read this too:
  • Are you bullish or bearish on Cormedix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cormedix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CorMedix Inc

I send you an email if I find something interesting about CorMedix Inc.


Comments

How you think about this?

Leave a comment

Stay informed about CorMedix Inc.

Receive notifications about CorMedix Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.